The Coming Deluge of Cancer and Immune Erosio...

The first step to solving the intractable jihadist threat in America is to properly diagnose it. The problem is not ISIS, a handful of “extremists,” or a certain strain of Islam. Islam itself demands that people participate in jihad and Sharia. It’s just that not everyone fully f ...  Show more

The conservative movement is facing a defining question: What comes after Donald Trump? In this episode, I sit down with State Freedom Caucus Network President Andy Roth to discuss the future of the American Right, the failures of the Republican establishment, and why state-level ...  Show more

Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ...

A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ...  Show more

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine suppli ...  Show more

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ...